Nu-Med Plus, Inc. Operating Income Loss

• Nu-Med Plus, Inc. showed an increase of +47.5% in Operating Income Loss from 2023 to 2024.
• This data is from Nu-Med Plus, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
• XBRL data for this metric is available from 2012 to 2024 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 13 years of available data (2012 to 2024), Nu-Med Plus, Inc.'s Operating Income Loss has grown by 75.5%.
• Historical annual values: Fiscal year 2024: -$63.3 thousand | Fiscal year 2023: -$120.5 thousand | Fiscal year 2022: -$182.2 thousand | Fiscal year 2021: -$839.4 thousand | Fiscal year 2020: -$1.99 million | Fiscal year 2019: -$1.02 million | Fiscal year 2018: -$1.17 million | Fiscal year 2017: -$466.5 thousand | Fiscal year 2016: -$1.22 million | Fiscal year 2015: -$946.5 thousand | Fiscal year 2014: -$1.15 million | Fiscal year 2013: -$233.6 thousand | Fiscal year 2012: -$258.2 thousand.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026